BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19486474)

  • 1. What's wrong with hazard-ranking systems? An expository note.
    Cox LA
    Risk Anal; 2009 Jul; 29(7):940-8. PubMed ID: 19486474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What's wrong with risk matrices?
    Cox LA
    Risk Anal; 2008 Apr; 28(2):497-512. PubMed ID: 18419665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a security vulnerability assessment process for the RAMCAP chemical sector.
    Moore DA; Fuller B; Hazzan M; Jones JW
    J Hazard Mater; 2007 Apr; 142(3):689-94. PubMed ID: 16920260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRIS from the inside.
    Mills A
    Risk Anal; 2006 Dec; 26(6):1409-10; discussion 1413. PubMed ID: 17184384
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving risk-based decision making for terrorism applications.
    Cox LA
    Risk Anal; 2009 Mar; 29(3):336-41; discussion 342-3. PubMed ID: 19243534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why IRIS is outdated: an additional perspective.
    Graham J
    Risk Anal; 2006 Dec; 26(6):1411-2. PubMed ID: 17184385
    [No Abstract]   [Full Text] [Related]  

  • 7. U.S. Environmental Protection Agency's activities to prepare for regulatory and risk assessment applications of genomics information.
    Benson WH; Gallagher K; McClintock JT
    Environ Mol Mutagen; 2007 Jun; 48(5):359-62. PubMed ID: 17567849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lifestage-specific approach to hazard and dose-response characterization for children's health risk assessment.
    Makris SL; Thompson CM; Euling SY; Selevan SG; Sonawane B
    Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):530-46. PubMed ID: 19085945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A ranking of European veterinary medicines based on environmental risks.
    Kools SA; Boxall A; Moltmann JF; Bryning G; Koschorreck J; Knacker T
    Integr Environ Assess Manag; 2008 Oct; 4(4):399-408. PubMed ID: 18563959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The perils and promise of modern risk assessment: the example of trichloroethylene.
    Kester JE; Clewell HJ
    Clin Occup Environ Med; 2004 Aug; 4(3):497-512, vi-vii. PubMed ID: 15325318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some limitations of aggregate exposure metrics.
    Cox LA; Popken DA
    Risk Anal; 2007 Apr; 27(2):439-45. PubMed ID: 17511710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human health risk assessment database, "the NHSRC toxicity value database": supporting the risk assessment process at US EPA's National Homeland Security Research Center.
    Moudgal CJ; Garrahan K; Brady-Roberts E; Gavrelis N; Arbogast M; Dun S
    Toxicol Appl Pharmacol; 2008 Nov; 233(1):25-33. PubMed ID: 18692516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An exploratory risk perception study of attitudes toward homeland security systems.
    Sanquist TF; Mahy H; Morris F
    Risk Anal; 2008 Aug; 28(4):1125-33. PubMed ID: 18627541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing and managing the hazards and risks of chemicals in the real world--the role of the EU's REACH proposal in future regulation of chemicals.
    Warhurst AM
    Environ Int; 2006 Dec; 32(8):1033-42. PubMed ID: 17055580
    [No Abstract]   [Full Text] [Related]  

  • 15. Some limitations of "Risk = Threat x Vulnerability x Consequence" for risk analysis of terrorist attacks.
    Cox LA
    Risk Anal; 2008 Dec; 28(6):1749-61. PubMed ID: 19000071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why risk is not variance: an expository note.
    Cox LA
    Risk Anal; 2008 Aug; 28(4):925-8. PubMed ID: 18554271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating and improving risk formulas for allocating limited budgets to expensive risk-reduction opportunities.
    Cox LA
    Risk Anal; 2012 Jul; 32(7):1244-52. PubMed ID: 22150317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The benefits and costs of disclosing information about risks: what do we know about right-to-know?
    Beierle TC
    Risk Anal; 2004 Apr; 24(2):335-46. PubMed ID: 15078304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lifestage approach to assessing children's exposure.
    Cohen Hubal EA; Moya J; Selevan SG
    Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):522-9. PubMed ID: 19025791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulating mercury: what's at stake?
    Gayer T; Hahn RW
    Science; 2005 Jul; 309(5732):244-5. PubMed ID: 16002599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.